Alterity Therapeutics ATHE
NASDAQ ATHE
$2.39 -0.04 (-1.65%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alterity Therapeutics (ATHE) Non Operating Income (2013 - 2015)

Updated

Analysis

Alterity Therapeutics (ATHE) Non Operating Income (2013 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 387.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Alterity Therapeutics 41.90 Mn -41.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 637,791.54
Dec 31, 2014 713,578.32
Dec 31, 2013 672,463.60
API Access

Alterity Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=ATHE&period=max&api_key=YOUR_API_KEY